aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin- or Irinotecan-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
- Yoshihiko Fujita
- , Masataka Taguri
- , Kentaro Yamazaki
- , Junji Tsurutani
- , Kazuko Sakai
- , Takahiro Tsushima
- , Michitaka Nagase
- , Hiroshi Tamagawa
- , Shinya Ueda
- , Takao Tamura
- , Yasushi Tsuji
- , Kohei Murata
- , Koichi Taira
- , Tadamichi Denda
- , Toshikazu Moriwaki
- , Sadao Funai
- , Takako Eguchi Nakajima
- , Kei Muro
- , Akihito Tsuji
- , Motoki Yoshida
- Kindai University
- Yokohama City University
- Shizuoka Cancer Center
- Jichi Medical University
- Osaka General Medical Center
- Tonan Hospital
- Suita Municipal Hospital
- Osaka City General Hospital
- Chiba Cancer Center
- University of Tsukuba
- St. Marianna University School of Medicine
- Aichi Cancer Center Hospital and Research Institute
- Kochi Health Sciences Center
- Osaka Medical and Pharmaceutical University
- Toranomon Hospital
- Nagoya Kyoritsu Hospital
- Osaka International Cancer Institute
- Kyushu University
- Ryugasaki Saiseikai Hospital
- Nagoya City University
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations